Results 161 to 170 of about 27,732,661 (195)

Use of Recombinant Human Bone Morphogenetic Protein-2 to Achieve Posterolateral Lumbar Spine Fusion in Humans: A Prospective, Randomized Clinical Pilot Trial 2002 Volvo Award in Clinical Studies

Spine, 2002
S. Boden, James Kang, H. Sandhu, J. Heller   +3 more
semanticscholar   +1 more source

Adverse Effects Associated With High-Dose Recombinant Human Bone Morphogenetic Protein-2 Use in Anterior Cervical Spine Fusion

Spine, 2006
L. Shields, G. Raque, S. Glassman, M. Campbell, T. Vitaz, J. Harpring, C. Shields   +6 more
semanticscholar   +1 more source

Bone morphogenetic protein‐2 and bone therapy: successes and pitfalls

The Journal of pharmacy and pharmacology, 2016
Bonnie Poon, Tram Kha, Sally Tran, C. Dass   +3 more
semanticscholar   +1 more source

Novel therapeutic core-shell hydrogel scaffolds with sequential delivery of cobalt and bone morphogenetic protein-2 for synergistic bone regeneration.

Acta Biomaterialia, 2015
R. Pérez, Joong-Hyun Kim, Jennifer O. Buitrago, I. Wall, H. Kim   +4 more
semanticscholar   +1 more source

Evaluation of complications associated with off-label use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in pediatric orthopaedics

Journal of materials science. Materials in medicine, 2016
N. Stiel, Tim N Hissnauer, M. Rupprecht, K. Babin, C. Schlickewei, J. Rueger, R. Stuecker, A. Spiro   +7 more
semanticscholar   +1 more source

Randomized study evaluating recombinant human bone morphogenetic protein-2 for extraction socket augmentation.

The Journal of Periodontology, 2005
Joseph P. Fiorellini, T. Howell, D. Cochran, J. Malmquist, Leslie C. Lilly, D. Spagnoli, J. A. Toljanic, Archie A. Jones, M. Nevins   +8 more
semanticscholar   +1 more source

Effect of Bone Morphogenetic Protein-2 in the Treatment of Long Bone Non-Unions

Journal of Clinical Medicine, 2021
Susanne Amler, Philipp A Michel, Dirk Wähnert   +2 more
exaly  

Bone Morphogenetic Protein-2 Causes Commitment and Differentiation in C3Hl0T1/2 and 3T3 Cells

Growth Factors, 1993
E A Wang, D I Israel
exaly  

Cancer risk after use of recombinant bone morphogenetic protein-2 for spinal arthrodesis.

Journal of Bone and Joint Surgery. American volume, 2013
E. Carragee, G. Chu, R. Rohatgi, E. Hurwitz, B. Weiner, S. T. Yoon, Garet C. Comer, B. Kopjar   +7 more
semanticscholar   +1 more source

Bone morphogenetic protein 7 in dormancy and metastasis of prostate cancer stem-like cells in bone

Journal of Experimental Medicine, 2011
Fei Xing, Kounosuke Watabe, Andy Wilber   +2 more
exaly